Avita Medical Inc. (RCEL)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 29 | 33 | 34 | 50 | 64 | 72 | 76 | 88 |
| Operating profit | $m | -43 | -35 | ||||||
| Net profit | $m | -27 | -25 | -27 | -35 | -62 | -49 | -43 | -26 |
| EPS reported | $ | -1.74 | -1.45 | ||||||
| Operating cashflow per share | $ | -1.12 | -0.79 | ||||||
| Capex per share | $ | 0.06 | 0.02 | ||||||
| FCF per share | $ | -1.18 | -0.77 | ||||||
| Free cash flow | $m | -33 | -24 | ||||||
| Net debt | $m | 25 | 36 | ||||||
| Book value equity | $m | -17 | -28 | ||||||
| Book value per share | $ | -0.60 | -0.91 | ||||||
| Number of shares | m | 27.86 | 30.75 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -5.77 | -3.45 | ||||||
| P/S LTM | x | 1.34 | 1.27 | ||||||
| P/FCF LTM | x | -2.92 | -4.07 | ||||||
| EV/EBITDA LTM | x | -3.20 | -3.83 | ||||||
| EV/Sales LTM | x | 1.84 | 3.10 | ||||||
| Earnings Yield LTM | % | -50.55% | -17.85% | ||||||
| FCF Yield | % | -34.26% | -24.55% | ||||||
| Quality | |||||||||
| ROE | % | +291.81% | +231.87% | ||||||
| ROIC | % | -1.13% | -1.37% | ||||||
| Operating margin | % | -59.40% | -46.57% | ||||||
| Gross margin | % | +82.13% | +81.56% | ||||||
| FCF/Sales | % | -45.99% | -31.20% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +11.45% | +17.71% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.72 | -0.49 | ||||||
| Net Debt/EBITDA | x | -0.87 | -1.14 | ||||||
| EBIT/Net interest | x | -8.50 | -6.52 | ||||||
| Net debt/market cap | % | +44.72% | +24.86% | ||||||
| Net debt/Equity | x | -1.49 | -1.28 | ||||||
| Gross debt/equity | x | -2.77 | -1.74 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free